Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Tryptase, a serine protease released exclusively from activated mast cells, has been implicated as a potential causative agent in asthma. Enzymatically active tryptase is comprised of four subunits, and heparin stabilizes the associated tetramer. Lactoferrin, a cationic protein released from activated neutrophils, binds tightly to heparin, therefore we investigated lactoferrin as an inhibitor of tryptase and found that it is both a potent (Ki' is 24 nM) and selective inhibitor. Size exclusion chromatography studies revealed that lactoferrin disrupted the quaternary structure of active tryptase. Lactoferrin was tested in an allergic sheep model of asthma; aerosolized lactoferrin (10 mg in 3 ml phosphate-buffered saline, 0.5 h before as well as 4 and 24 h after inhalation challenge by Ascaris suum) abolished both late-phase bronchoconstriction (no significant increase in specific lung resistance 4 to 8 h following provocation, p < 0.05 versus vehicle treatment) and airway hyperresponsiveness (no detectable increase in airway sensitivity to carbachol challenge 24 h after antigen challenge, p < 0.05 versus vehicle). These data suggest tryptase involvement in both late-phase bronchoconstriction and airway hyperreactivity and furthermore suggest that a physiological function of neutrophil lactoferrin is the inhibition of tryptase released from mast cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Establishment of an immature mast cell line from a patient with mast cell leukemia
Butterfield, J. H., Weiler, D., Dewald, G., & Gleich, G. J. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90050-1 · Cited by 737
Schwartz, L. B., Yunginger, J. W., Miller, J., Bokhari, R., & Dull, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114051 · Cited by 456 · cited 1×
“The presence of tryptase in biological matrices is an indicator of mast cell degranulation in anaphylaxis and allergic reaction ( 17 , 18).”
BackgroundTryptase from human pulmonary mast cells. Purification and characterization
Schwartz, L. B., Lewis, R. A., & Austen, K. F. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68496-6 · Cited by 419
Mast cell tryptase is a mitogen for cultured fibroblasts
Ruoss, S. J., Hartmann, T., & Caughey, G. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115330 · Cited by 390
Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin
Lohi, J., Kesksi‐Oja, J., & Harvima, I. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500402 · Cited by 182 · cited 2×
“However, tryptase cleaves biologically important proteins and peptides in vitro , and, thus, several pro-inflammatory properties have been proposed for the enzyme: the activation of collagenase (9) and gelatinase (10); the degradation of fibronectin ( 10 ), fibrinogen (11), and vasoactive intestinal peptide (12); and…”
Background
Cited by
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Lactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Lactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
Legrand, D., Elass, E., Carpentier, M., & Mazurier, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5370-2 · Cited by 420
Pejler, G., Åbrink, M., Ringvall, M., & Wernersson, S. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)95006-3 · Cited by 320
Emerging Health Properties of Whey Proteins and Their Clinical Implications
Krissansen, G. W. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719652 · Cited by 313
Metadata
- Authors
- ELROD, K. C., MOORE, W. R., ABRAHAM, W. M., & TANAKA, R. D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-08-01
- Volume
- 156
- Issue
- 2
- Pages
- 375-381
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2129028964
- Cited by
- 109
- References
- 5
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep. https://app.cochat.ai/papers/10.1164/ajrccm.156.2.9607012
- The paper
- ELROD, K. C., MOORE, W. R., ABRAHAM, W. M., & TANAKA, R. D. (1997). Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.156.2.9607012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.